Inve India ▾

Indian Emuls share price & results

Indian Emuls· Chemicals· Commodities

Results to
Mar 2026
Latest analysed call
Q4 FY26
Ownership as of
Mar 2026

Maharashtra-based manufacturer of specialty chemical emulsifiers — esters, imidazolines, phosphate esters and wax emulsions — supplying personal care, cleaning, oil & gas and industrial customers across 9 countries.

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue83.0 ₹ crore+66.0% YoYQuarterly, as filedQuarter to Mar 2026Revenue from operations as filed.
Operating margin13.0 %−6.0 pts YoYOperating profit / revenueQuarter to Mar 2026For the quarter; a change is in percentage points.
Net profit6.0 ₹ crore0.0% YoYQuarterly, as filedQuarter to Mar 2026Profit after tax as filed.
Return on equityUnavailable−9.7 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM · period unavailableNot in the analysed materials. No older figure is substituted.
Free cash flow margin-41.26 %−2.0 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)Unavailable+7.7 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM · period unavailableNot in the analysed materials. No older figure is substituted.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Mar 2026

Guidance

What management said, and what became of it

1 of 6 judged targets kept · 6 open · verdicts reflect calls analysed to Q4 FY26.

Indian Emuls management guidance track record on Inve: 12 targets tracked across analysed earnings calls (1 achieved, 5 missed, 6 open).

TargetOriginal wordingSaidLatest callVerdict
Revenue Growth40% to 45% CAGR over the next three years
Call transcript, Q4 FY25 · 28 May 2025
Q4 FY25Q4 FY26:FY26 revenue grew 57% YoY to ₹159.87 crores, missing the revised guidance of 'upward of 100% minimum'.
Call transcript, Q4 FY26 · 6 Jun 2026
Missed
Australian Subsidiary RevenueINR 75 crores over the next three years
Call transcript, Q4 FY25 · 28 May 2025
Q4 FY25Q4 FY26:Management reiterated the target of ₹75 crores over three years (FY26-FY28), stating it is still achievable. Initial shipments began in Q4 FY26.
Call transcript, Q4 FY26 · 6 Jun 2026
On Track

Source: Inve Guidance Tracker for Indian Emuls · to Q4 FY26

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

5 of Indian Emuls's 12 targets were missed. See which ones, and which are quietly gone. The 2 above are the free sample; 10 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. Pro opens 100 a month, ₹499.
See the full record

Price

₹32.7 −11.62% · −₹4.3

Last close 27 Oct 2026 · NSE · INR · Source: Inve

Performance −70.1% 1Y

₹40₹60₹80₹100₹120Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Oct 26Q2 FY26 — 10 Nov 2025Q4 FY26 — 5 Jun 2026

1Y: ₹109.2 on 24 Oct 2025 → ₹32.7. High ₹122.5 (12 Nov 2025), low ₹32.7 (27 Oct 2026).

Previous close
₹37
Market cap
₹91 Cr
52-week range
₹32.7 – ₹122.5
One year
−68.33%
Price to earnings (FY ending Mar 2026)
5.71×
Return on equity (FY ending Mar 2026)
13.97%

Overview

Symbol
NSE:IEML
Sector
Chemicals
Industry
Commodities
Exchange
NSE
Currency
INR

What Indian Emuls does

Based on the company's own presentations, annual report and earnings calls.

Indian Emulsifiers Limited manufactures specialty chemical emulsifiers and surfactants — including esters, imidazolines, phosphate esters, wax emulsions, amphoterics, SMO & PIBSA emulsifiers and formulated products — used as functional additives in personal care, cleaning, oil & gas, mining, textiles and agrochemical applications. It operates a manufacturing and R&D facility at MIDC Lote Parshuram, Ratnagiri (Maharashtra), and earns revenue by supplying these emulsifying agents to industrial and consumer-product manufacturers domestically and in export markets. It has also set up subsidiaries abroad — Southern Emulsifiers in Australia (mining-explosives emulsifiers), Polaris Specialty Chemicals Inc. in the US (import distribution, customs clearance and last-mile delivery), and Spartan Professional Products (finished home & personal care formulations) — extending the business beyond raw-material supply into distribution and branded finished goods.

Segments

  • Specialty emulsifiers manufacturing (India)
  • Southern Emulsifiers (Australia)
  • Polaris Specialty Chemicals Inc. (US)
  • Spartan Professional Products
Installed manufacturing capacity
12,000 MTPA (up from 2,400 MTPA)
Manufacturing facilities
1 operational (MIDC Lote Parshuram, Ratnagiri) + 1 greenfield facility under construction (Plot C-3, Lote Parshuram MIDC), expected online by end of FY27
Product portfolio
125+ specialty chemicals
Global presence
9 countries
International subsidiaries
3 — Southern Emulsifiers (Australia), Polaris Specialty Chemicals Inc. (US), Spartan Professional Products
Reactor batch size range
100 kg – 8,000 kg per batch
Founded 2020Headquarters Mumbai, Maharashtra, India Company website

How the price took the results

close before → close after

Q4 FY26
−2.4%
6 Jun
Q2 FY26
+20.0%
10 Nov

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Your own record

Start an Inve Case for Indian Emuls

Free account: one company. Everything above stays public.

Write why you follow Indian Emuls and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds